Released on: May 28, 2014, 5:11 pm (EDT)
Author: HD Biosciences Co.,Ltd.
Industry: Pharmaceuticals, Biotech
Shanghai, May 28, 2014 — /EPR NETWORK/ — HD Biosciences Co., Ltd. (HDB) and E. J. Corey Institute of Biomedical Research (CIBR) announced that they have reached a risk-sharing agreement on collaborative drug discovery and development in the therapeutic areas of infectious diseases, metabolic diseases, and oncology. This joint effort will focus on both international and Chinese markets to provide innovative medicines for unmet healthcare needs. The agreement includes lead candidate selection pre-clinical development, IND filing, clinical trials, and NDA approvals. Both companies will share financial returns from any successes or products launches.
Released on: April 10, 2014, 7:57 am (EDT)
Author: EMS Healthcare
Ellesmere Port, UK, April 10, 2014 — /EPR NETWORK/ — EMS Healthcare has announced that it has achieved ISO accreditation for the fourth consecutive year.
It is the latest in a long line of endorsements that the UK event marketing organisation has achieved continuously and maintained over the years. It marks EMS Healthcare as a first-class employer.
By investing in standards of best practice, EMS Healthcare not only gives their customers peace of mind and the confidence to do business with them, but they are also able to recruit the best and brightest talent in the event trailer hire and mobile medical accommodation industry.
Released on: November 14, 2013, 1:02 pm
The multi-discipline exhibition examines healthcare through art produced in six countries, from Kenya to Vietnam.
November 14, 2013, 1:02 pm — /EPR NETWORK/ — The Wellcome Collection’s winter exhibition opens this week. It’s called Foreign Bodies, Common Ground and offers a fascination look at health all over the globe through art, including painting, photography, sculpture, film and performance, funded by the Wellcome Trust in six countries, Kenya, Malawi, South Africa, Thailand, Vietnam and the UK. It is typical of the Wellcome Collection’s dedication to combining art and science, marrying the two cultures with imagination and flair. The Wellcome Collection is located on the Euston Road, close to dozens of cheap London hotels. For the latest room rates, see LondonTown.com, which has details for numerous cheap hotels in London.
Released on: November 12, 2013, 9:58 am
Author: Cyndi Krupp
Industry: Non Profit
November 12, 2013, 9:58 am — /EPR NETWORK/ — Even with insurance, Steve Barnes’ medical bills now total in the 100,000s of dollars and growing. He is currently institutionalized because insurance will not cover life saving medication if he was home.
Released on: May 31, 2013, 4:02 am
Author: Andy AuGustin
Atlanta, GA, May 31, 2013, 4:02 am — /EPR NETWORK/ — BlueFire Marketing, a fully integrated marketing firm, announced today the launch of a text message marketing reminder service for healthcare providers. This service allows them to automatically remind patients of upcoming appointments. This reduces time and cost for healthcare providers who manually and individually call patients to remind them of their appointments.
Released on: January 22, 2013, 11:46 am
Author: Biosortia Pharmaceuticals
Industry: Biotech, Healthcare, Chemicals, Pharmaceuticals
Biosortia Pharmaceuticals Hires Kurt Dieck as President and CEO to Accelerate Strategy to Develop and License New Highly Active Compounds from Unculturable Aquatic Microbial Consortia
Dublin, Ohio, January 22, 2013, 11:46 am — /EPR NETWORK/ — Kurt Dieck formerly SVP of Strategy and Business Execution at Cardinal Health, will lead early stage drug discovery business at Biosortia Pharmaceuticals. Dieck was named President and CEO in November 2012 and has quickly identified other key executives, including Dr. Guy Carter, former Natural Product head at Wyeth Pharmaceuticals, as his Chief Science Officer. In conjunction, other collaboration partners have joined the team, including NOAA (National Oceanic and Atmospheric Administration), NCI (National Cancer Institute) and key universities, to strategically accelerate the development of novel drug leads in the therapeutic areas of cancer, infectious diseases, inflammation and neurological disorders. Biosortia Pharmaceuticals has seen promising early results with dozens of novel compounds having already been requested, and are under evaluation with NCI and Eli Lilly.
Released on: June 12, 2012, 6:38 am
Author: Konrad Trope
E-MAILS from former employee of San Diego Surgery Center show accusations against center are false
June 12, 2012, 6:38 am — /EPR NETWORK/ — 1 800 GET THIN has called a lawsuit filed against it a fantasy and lacking in credibility. The lawsuit, Meyle v. 1 800 GET THIN, was filed in LA Superior Court (BC486169) on Thursday, and charges that San Diego Ambulatory Surgery Center failed to properly sterilize its instruments on December 30 and 31 of 2011.
Released on: September 20, 2011, 12:01 pm
As the pressure on the NHS to find efficiency savings increases, several trusts are looking to adopt a pioneering approach to varicose vein treatment that saves resources, while improving patient outcomes.
If adopted by all hospitals, The VNUS Closure procedure for the treatment of varicose veins, endorsed by the NHS National Innovation Centre, could save the health service around £17million.
Released on: September 19, 2011, 3:13 pm
Varicose veins can be painful and unsightly, with treatment often meaning surgery under general anaesthetic and a long recovery period.
While the traditional surgical approach has meant painful vein stripping, many UK hospitals now offer minimally invasive catheter technology that enables even severe varicose veins to be successfully treated in an outpatient setting, under a local anaesthetic.
Released on: September 16, 2011, 2:30 pm
A revolutionary new treatment for varicose veins is proving a successful alternative to surgery.
The VNUS ClosureFast catheter is a minimally invasive alternative treatment, which doctors claim, results in less pain and bruising than traditional vein stripping surgery.
Using the Closure system, doctors close the diseased veins by inserting the closure catheter into a vein and heating the vein wall using temperature-controlled RF energy. As it is catheter-based, it results in little to no scarring.